GPVI inhibitors (SignaBlok)

N/A

Report date: 2025/03/20 14:59:03
NME

Base Information

Drug NameGPVI inhibitors (SignaBlok)
Drug Alias Nameglycoprotein VI inhibitors (SignaBlok)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsPlatelet membrane glycoprotein VI inhibitors
TargetsPlatelet membrane glycoprotein VICoagulation factor
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignaBlok Inc
China Registration ClassN/A

Develop Information

Active CompaniesSignaBlok Inc
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A